Intraday volatility continued as key benchmark indices alternately moved between positive and negative terrain in early afternoon trade. The barometer index, the S&P BSE Sensex, was currently down 6.17 points or 0.03%, off close to 130 points from the day's high and up about 30 points from the day's low. The market breadth, indicating the overall health of the market, was positive.
Pharma stocks gained. Dr. Reddy's Laboratories rose after the company said it has launched anti-bacterial Moxifloxacin generic in the US market on 4 March 2014. Most capital goods stocks gained.
The market edged higher in early trade on firm Asian stocks. The Sensex and the 50-unit CNX Nifty, both, hit their highest level in nearly six weeks. A bout of volatility was witnessed as key benchmark indices trimmed gains in morning trade. Intraday volatility continued as key benchmark indices recovered from lower level after giving away almost entire intraday gains in mid-morning trade. The Sensex slipped into the red later. Intraday volatility continued as key benchmark indices alternately moved between positive and negative terrain in early afternoon trade.
Foreign institutional investors (FIIs) bought shares worth a net Rs 185.61 crore on Tuesday, 4 March 2014, as per provisional data from the stock exchanges.
At 12:20 IST, the S&P BSE Sensex was down 6.17 points or 0.03% to 21,203.56. The index fell 33.57 points at the day's low of 21,176.16 in early afternoon trade. The index jumped 123.47 points at the day's high of 21,333.20 in early trade, its highest level since 24 January 2014.
The CNX Nifty was down 4.35 points or 0.07% to 6,293.60. The index hit a low of 6,287.80 in intraday trade. The index hit a high of 6,333.90 in intraday trade, its highest level since 23 January 2014.
The BSE Mid-Cap index was up 31.73 points or 0.48% at 6,597.32. The BSE Small-Cap index was up 9.72 points or 0.15% at 6,525.51. Both these indices outperformed the Sensex.
The market breadth, indicating the overall health of the market, was positive. On BSE, 1,187 shares gained and 1,168 shares fell. A total of 119 shares were unchanged.
Among the 30-share Sensex pack, 16 stocks fell and rest of them rose. Tata Power Company (down 2.94%), Bharti Airtel (down 1.48%) and Tata Motors (down 1.07%) edged lower from the Sensex pack.
Pharma stocks gained. Cipla (up 0.86%), Lupin (up 0.6%), Ranbaxy Laboratories (up 0.59%) and Sun Pharmaceutical Industries (up 0.27%) rose.
Dr. Reddy's Laboratories rose 0.95% after the company said it has launched anti-bacterial Moxifloxacin generic in the US market on 4 March 2014. The company made the announcement during trading hours today, 5 March 2014.
Dr. Reddy's Laboratories announced that it has launched Moxifloxacin Hydrochloride tablets, 400 milligram (mg), a therapeutic equivalent generic version of Avelox (Moxifloxacin HCI) tablets 400 mg in the US market on Tuesday, 4 March 2014, following the approval by the United States Food & Drug Administration (US FDA).
The Avelox (Moxifloxacin HCI) tablets brand had US sales of approximately $195 million for the twelve months period ended 31 December 2013 according to IMS Health data. Avelox tablets are used in adults for the treatment of infections of the lungs, airways and sinuses.
Dr. Reddy's Moxifloxacin Hydrochloride tablets, 400 mg is available in bottle counts of 30, the company said in a statement..
Pharma stocks gained. Dr. Reddy's Laboratories rose after the company said it has launched anti-bacterial Moxifloxacin generic in the US market on 4 March 2014. Most capital goods stocks gained.
The market edged higher in early trade on firm Asian stocks. The Sensex and the 50-unit CNX Nifty, both, hit their highest level in nearly six weeks. A bout of volatility was witnessed as key benchmark indices trimmed gains in morning trade. Intraday volatility continued as key benchmark indices recovered from lower level after giving away almost entire intraday gains in mid-morning trade. The Sensex slipped into the red later. Intraday volatility continued as key benchmark indices alternately moved between positive and negative terrain in early afternoon trade.
Foreign institutional investors (FIIs) bought shares worth a net Rs 185.61 crore on Tuesday, 4 March 2014, as per provisional data from the stock exchanges.
At 12:20 IST, the S&P BSE Sensex was down 6.17 points or 0.03% to 21,203.56. The index fell 33.57 points at the day's low of 21,176.16 in early afternoon trade. The index jumped 123.47 points at the day's high of 21,333.20 in early trade, its highest level since 24 January 2014.
The CNX Nifty was down 4.35 points or 0.07% to 6,293.60. The index hit a low of 6,287.80 in intraday trade. The index hit a high of 6,333.90 in intraday trade, its highest level since 23 January 2014.
The BSE Mid-Cap index was up 31.73 points or 0.48% at 6,597.32. The BSE Small-Cap index was up 9.72 points or 0.15% at 6,525.51. Both these indices outperformed the Sensex.
The market breadth, indicating the overall health of the market, was positive. On BSE, 1,187 shares gained and 1,168 shares fell. A total of 119 shares were unchanged.
Among the 30-share Sensex pack, 16 stocks fell and rest of them rose. Tata Power Company (down 2.94%), Bharti Airtel (down 1.48%) and Tata Motors (down 1.07%) edged lower from the Sensex pack.
Pharma stocks gained. Cipla (up 0.86%), Lupin (up 0.6%), Ranbaxy Laboratories (up 0.59%) and Sun Pharmaceutical Industries (up 0.27%) rose.
Dr. Reddy's Laboratories rose 0.95% after the company said it has launched anti-bacterial Moxifloxacin generic in the US market on 4 March 2014. The company made the announcement during trading hours today, 5 March 2014.
Dr. Reddy's Laboratories announced that it has launched Moxifloxacin Hydrochloride tablets, 400 milligram (mg), a therapeutic equivalent generic version of Avelox (Moxifloxacin HCI) tablets 400 mg in the US market on Tuesday, 4 March 2014, following the approval by the United States Food & Drug Administration (US FDA).
The Avelox (Moxifloxacin HCI) tablets brand had US sales of approximately $195 million for the twelve months period ended 31 December 2013 according to IMS Health data. Avelox tablets are used in adults for the treatment of infections of the lungs, airways and sinuses.
Dr. Reddy's Moxifloxacin Hydrochloride tablets, 400 mg is available in bottle counts of 30, the company said in a statement..
Source: News in Hindi
No comments:
Post a Comment